Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Single and multiple exposure tolerance study of polystyrene sulfonate gel: a phase I safety and colposcopy study.

Mauck CK, Weiner DH, Ballagh SA, Creinin MD, Archer DF, Schwartz JL, Pymar HC, Lai JJ, Rencher WF, Callahan MM; CONRAD.

Contraception. 2004 Jul;70(1):77-83.

2.

Single and multiple exposure tolerance study of cellulose sulfate gel: a Phase I safety and colposcopy study.

Mauck C, Weiner DH, Ballagh S, Creinin M, Archer DF, Schwartz J, Pymar H, Lai JJ, Callahan M.

Contraception. 2001 Dec;64(6):383-91.

PMID:
11834238
3.

A randomized Phase I vaginal safety study of three concentrations of C31G vs. Extra Strength Gynol II.

Mauck CK, Weiner DH, Creinin MD, Barnhart KT, Callahan MM, Bax R.

Contraception. 2004 Sep;70(3):233-40.

PMID:
15325893
4.

Safety study of nonoxynol-9 as a vaginal microbicide: evidence of adverse effects.

Stafford MK, Ward H, Flanagan A, Rosenstein IJ, Taylor-Robinson D, Smith JR, Weber J, Kitchen VS.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Apr 1;17(4):327-31.

PMID:
9525433
5.

Study of the vaginal tolerance to Acidform, an acid-buffering, bioadhesive gel.

Amaral E, Faúndes A, Zaneveld L, Waller D, Garg S.

Contraception. 1999 Dec;60(6):361-6.

PMID:
10715372
6.

Fourteen-day safety and acceptability study of the universal placebo gel.

Schwartz JL, Ballagh SA, Kwok C, Mauck CK, Weiner DH, Rencher WF, Callahan MM.

Contraception. 2007 Feb;75(2):136-41. Epub 2006 Oct 25.

PMID:
17241844
7.

Phase I randomized safety study of twice daily dosing of acidform vaginal gel: candidate antimicrobial contraceptive.

Keller MJ, Carpenter CA, Lo Y, Einstein MH, Liu C, Fredricks DN, Herold BC.

PLoS One. 2012;7(10):e46901. doi: 10.1371/journal.pone.0046901. Epub 2012 Oct 8.

8.

A phase I comparative study of three contraceptive vaginal films containing nonoxynol-9. Postcoital testing and colposcopy.

Mauck CK, Baker JM, Barr SP, Johanson WM, Archer DF.

Contraception. 1997 Aug;56(2):97-102.

PMID:
9315418
9.
10.

Expanded Phase I safety and acceptability study of 6% cellulose sulfate vaginal gel.

Malonza IM, Mirembe F, Nakabiito C, Odusoga LO, Osinupebi OA, Hazari K, Chitlange S, Ali MM, Callahan M, Van Damme L.

AIDS. 2005 Dec 2;19(18):2157-63.

PMID:
16284466
11.

Effectiveness of an optimized benzalkonium chloride gel as vaginal contraceptive: a randomized controlled trial among Chinese women.

Li W, Huang Z, Wu Y, Wang H, Zhou X, Xiao Z, Ding X, Xu J.

Contraception. 2013 Jun;87(6):756-65. doi: 10.1016/j.contraception.2012.09.012. Epub 2012 Oct 22.

PMID:
23089047
12.

Vaginal safety after use of a bioadhesive, acid-buffering, microbicidal contraceptive gel (ACIDFORM) and a 2% nonoxynol-9 product.

Amaral E, Perdigao A, Souza MH, Mauck C, Waller D, Zaneveld L, Faundes A.

Contraception. 2006 May;73(5):542-7. Epub 2006 Feb 17.

PMID:
16627043
13.

Mucosal integrity and inflammatory markers in the female lower genital tract as potential screening tools for vaginal microbicides.

Su HI, Schreiber CA, Fay C, Parry S, Elovitz MA, Zhang J, Shaunik A, Barnhart K.

Contraception. 2011 Nov;84(5):525-32. doi: 10.1016/j.contraception.2011.02.010. Epub 2011 Mar 29.

14.

Contraceptive efficacy of a novel spermicidal microbicide used with a diaphragm: a randomized controlled trial.

Barnhart KT, Rosenberg MJ, MacKay HT, Blithe DL, Higgins J, Walsh T, Wan L, Thomas M, Creinin MD, Westhoff C, Schlaff W, Archer DF, Ayers C, Kaunitz A, Das S, Moench TR.

Obstet Gynecol. 2007 Sep;110(3):577-86.

PMID:
17766603
15.

Cellulose sulfate: tolerance and acceptability of penile application.

Mauck C, Frezieres R, Walsh T, Robergeau K, Callahan M.

Contraception. 2001 Dec;64(6):377-81.

PMID:
11834237
16.

Safety evaluation of nonoxynol-9 gel in women at low risk of HIV infection.

Van Damme L, Niruthisard S, Atisook R, Boer K, Dally L, Laga M, Lange JM, Karam M, Perriens JH.

AIDS. 1998 Mar 5;12(4):433-7.

PMID:
9520174
17.

A randomized, double-blind, placebo-controlled safety and acceptability study of two Invisible Condom formulations in women from Cameroon.

Mbopi-Keou FX, Trottier S, Omar RF, Nkele NN, Fokoua S, Mbu ER, Giguere JF, Domingo MC, Piret J, Tsague L, Zekeng L, Mwatha A, Mâsse B, Bergeron MG.

Contraception. 2009 Nov;80(5):484-92. doi: 10.1016/j.contraception.2009.03.020. Epub 2009 May 23.

PMID:
19835725
18.

Safety, tolerability, and pharmacokinetics of SPL7013 gel (VivaGel): a dose ranging, phase I study.

O'Loughlin J, Millwood IY, McDonald HM, Price CF, Kaldor JM, Paull JR.

Sex Transm Dis. 2010 Feb;37(2):100-4. doi: 10.1097/OLQ.0b013e3181bc0aac.

PMID:
19823111
19.

Development and characterization of bioadhesive vaginal films of sodium polystyrene sulfonate (PSS), a novel contraceptive antimicrobial agent.

Garg S, Vermani K, Garg A, Anderson RA, Rencher WB, Zaneveld LJ.

Pharm Res. 2005 Apr;22(4):584-95. Epub 2005 Apr 7.

PMID:
15846466
20.

Factors affecting the reproducibility and validity of colposcopy for product development: review of current literature.

Ballagh S.

J Acquir Immune Defic Syndr. 2004 Oct;37 Suppl 3:S152-5. Review.

PMID:
16419264

Supplemental Content

Support Center